ask="N/A"
ask_size="N/A"
average_daily_volume="38522"
bid="11.00"
bid_size="300"
book_value="5.24"
change="-0.21"
change_from_200_day_moving_average="-6.28"
change_from_50_day_moving_average="-2.99"
change_from_52_week_high="-13.65"
change_From_52_week_low="2.69"
change_in_percent="-1.63%"
close="12.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.80"
ebitda="-32.35M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="0.46"
ex_dividend_date="N/A"
float_shares="7128000"
high="13.24"
high_52_weeks="26.36"
last_trade_date="3/15/2017"
last_trade_price="12.71"
last_trade_size="933"
last_trade_time="4:00pm"
low="12.30"
low_52_weeks="10.02"
market_capitalization="213.36M"
moving_average_200_day="18.99"
moving_average_50_day="15.70"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="N/A"
open="12.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-33.07%"
percent_change_from_50_day_moving_average="-19.03%"
percent_change_from_52_week_high="-51.78%"
percent_change_from_52_week_low="+26.85%"
previous_close="12.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="27.63"
price_per_book="2.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16787000"
short_ratio="6.28"
stock_exchange="NGM"
symbol="PTGX"
volume="25358"
weeks_range_52="10.02 - 26.36"
